⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001901033

de Garidel Marc

Reports to the SEC for 1 company · BOSTON, MA

Transactions

6

Companies

1

Filings

3

CIK

0001901033

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-02-24	CinCor Pharma, Inc.U Disposition from Tender	Director, Chief Executive Officer	UDisposition from Tender	−12.5K sh	—	—	200,000
2023-02-24	CinCor Pharma, Inc.D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−200K sh	—	—	0
2023-02-24	CinCor Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−726K sh	—	—	0
2023-02-24	CinCor Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−602K sh	—	—	0
2023-01-26	CinCor Pharma, Inc.A Award	Director, Chief Executive Officer	AAward	+200K sh	—	—	212,500
2022-01-11	CinCor Pharma, Inc.P Purchase	Director, Chief Executive Officer	PPurchase	+12.5K sh	$16.00	+$200K	12,500

Recent filings

3

Accepted (ET)
Feb 244
de Garidel Marc0001209191-23-012890
SEC(opens sec.gov)
Jan 304
de Garidel Marc0001209191-23-005596
SEC(opens sec.gov)
Jan 134
de Garidel Marc0001209191-22-003186
SEC(opens sec.gov)

Companies

1

CinCor Pharma, Inc.Director, Chief Executive Officer

Address

C/O CINCOR PHARMA, INC 200 CLARENDON STREET, 6TH FLOOR

BOSTON, MA, 02116